Objective and Rationale. The purpose of this study is to evaluate the degree of fibroid shrinkage which well correlates with symptom regression, and thus to assess the effectiveness of the procedure Method. 31 patients were included in the trial after selection. All the patients were thoroughly evaluated before embolization, the following day and at a month after but also at 3 months for 10 of them. A certain protocol was followed passing through well established steps. The purpose was to discover and rule out any associated possible disease and to assess and grade the symptoms, ultrasound and angiographic aspects. Results. Regarding the uterus, its volume evolution registered a descending trend, the mean decrease at 30 days being of 25% (-81,6 cm³) and at 90 days of 52%(-173,15 cm³). The fibroids also decreased statistically, the mean global variation at 30 days registering a decrease of -17,66 cm³(27%) and 61% at day 90. The mean global reduction at 30 days was of 44% (-33,18 cm³) and of 62% (-60,85 cm³) at 90 days. Absence of uterine anastomoses lead to proper fibroid decrease whereas their presence diminished the chances. Conclusions. The uterine and fibroid volumes registered a statistical volume decrease at 30 and 90 days in comparison with the volumes before embolization. Absence of uterine anastomoses led to proper fibroid decrease. Longer evaluation time is needed for an accurate evaluation of volume reduction degree.
Introduction
Leiomyomas are the most frequent benign uterine tumors encountered in gynecology at reproductive age [1] . Though going in most cases unnoticed, many patients discover having fibroids after complaining about one of the following: bulk related symptoms, pain, infertility and bleeding related symptoms [2, 1] . In conclusion, uterine fibroids are a modern day problem, which needs proper conservative and efficient treatment. There is continuous research regarding the development of an ideal method of minimally-invasiveness, safety and well tolerance for treating such cases. Many conservative operatory or non-operatory techniques have been developed: laparoscopic uterine artery ligation, myomectomy, high intensity focused ultrasound etc. among which uterine artery embolization is also cited [1, [3] [4] [5] . According to Dr. Jaques Merland, the first uterine artery embolization procedure was made in 1974 on a patient with uncontrollable bleeding and poor candidate for operation; it was a success [6] . The first published report in English literature though appeared in 1995 by Dr Charles Ravina [6] [7] [8] . Our clinic in collaboration with the interventional radiology department has a large experience related to this field. In regards to this we consider uterine artery embolization to be a known, reproducible and safe procedure, not only used for the treatment of fibroids but also for uncontrollable hemorrhages (postpartum [9, 10] , arterial venous malformations [11] , cervical end stage cancer [12] , post curettage molar pregnancy [13] ), ectopic pregnancy [14] and adenomyosis [15] . This technique obtains a fibroid reduction by obstructing its vessels with specially selected embolic particles via catheterization of the uterine arteries [4] . It is stated that leiomyoma shrinkage and devascularization is well correlated with symptom reduction and quality of life improvement [5, 16] .The purpose of this study is to evaluate the degree of shrinkage closely tied to clinical alleviation, and thus to assess the effectiveness of the cited method [5, 16] .
Materials and methods
The study regarding uterine artery embolization of leiomyomas was held between 04.2011-05.2012 at the Bucharest University Emergency Hospital with approval of the institutional management and the informed consent of each patient. 60 patients were initially included in the trial, no sex or ethnic based differences being present; among those only 31 patients came to the follow-up thus remaining in the trial. All the patients were thoroughly evaluated before, the following day and at a month after embolization, 10 being also at 3 months assessed. A certain protocol was followed passing through wellestablished steps for each period. Pre embolization protocol -All patients went through the following examinations: clinical evaluation; blood tests (full blood count, biochemistry, coagulogram, oxidative stress factors, hormones, growth factors); urine exam and urinary culture; pap smear, cervical and vaginal cultures; transvaginal ultrasound with Doppler examination. The purpose was to rule out any associated possible malignant disease, pregnancy or genito-urinary infections; to discover any other illnesses; and to assess and grade the symptoms, the location, type, number, complications, vascularization and volume of the uterus and fibroids. After a complete diagnosis, each patient was informed, a discussion taking place. The patients were ruled out or accepted based on the uterine artery fibroid embolization and angiography indications. The embolization procedure, evolution, possible risks and complications were explained, all patients giving an informed consent.
Embolization procedure-In all patients the left brachial artery was catheterized up to the uterine arteries; upon failure, access via the right brachial artery was established. An angiogram showing the vascularization of the uterus, fibroma and communications (left to right and utero-ovarian anastomoses) was obtained. The next step consisted of bilateral occlusion of the vessels nourishing the fibroids by injecting 1 to 4 units of microspheres ranging from 355-1100 micrometers in diameter combined with half a unit gelaspon particles depending on the dimensions and vascularization of the arteries needing to be occluded. The angiographic end-point was obtained when stasis on the fibroid arteries occurred in combination with persistence of anterograde flow in the uterine arteries-the pruned tree angiographic appearance [17] .
Post-embolization hospital stay-The patient remained at bed rest until being able to resume normal functions. Immobilization of the former catheterized arm was considered necessary for 6 hours. Each patient was carefully monitored (blood pressure, oxygen saturation, diuresis, temperature, pain scale, symptoms) being medicated upon need for pain, and nausea. The second day another assessment took place: clinical examination and transvaginal ultrasound. The vast majority of patients had only an over-night stay, being let out the following for improvement of symptoms. Post-embolization protocolThe patients went through the same procedures as before embolization except the pap-smear at the following periods of time: 1 month, 3 months.
Results
Uterus and fibroid number, placement and trend -Out of the 31 patients evaluated at 30 days, 71% (22 patients) registered uterine volume reduction; only 10 came at de 90 days follow-up of which 80%(8 patients) registered a shrinkage ( Table 1, Fig. 1, 2 ). (Fig. 3) . (Fig. 3) . 57±56,11 cm³ the dominant 79±45,59 cm (Fig. 4) 
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